Thousands of individuals in England with type 1 diabetes are set to receive access to a groundbreaking technology known as artificial pancreas.
Type 1 diabetes
University of East Anglia researchers have developed a "hybrid closed-loop technology" that improves gestational diabetes self-care.
Maker of smart insulin pen caps and a leader in diabetes technology and is being bought by longtime business partner Abbot Laboratories.
